Wildon Farwell
Equibles does not estimate personal net worth.
About Wildon Farwell
Dyne Therapeutics, Inc. reported in an 8-K filed September 3, 2024 that Wildon Farwell resigned as chief medical officer.
“On September 3, 2024, the Company issued a press release announcing the hiring of Doug Kerr as chief medical officer, Johanna Friedl-Naderer as chief commercial officer and Lucia Celona as chief human resources officer and the resignations of Dr. McNeill, Ms. High and Wildon Farwell, the chief medical officer.”
Affiliation history
-
Dyne Therapeutics, Inc. (DYN)
Proxy statement
Start not stated–2024-09-03